Pazufloxacin
- Generic Name
- Pazufloxacin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H15FN2O4
- CAS Number
- 127045-41-4
- Unique Ingredient Identifier
- 4CZ1R38NDI
- Background
Pazufloxacin is under investigation in clinical trial NCT02592096 (Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol).
- Indication
用于敏感菌所致的呼吸道感染、泌尿道感染，妇科、外科、耳鼻喉科和皮肤科等感染的治疗。
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.
- First Posted Date
- 2018-10-04
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Laboratorios Sophia S.A de C.V.
- Target Recruit Count
- 46
- Registration Number
- NCT03696342
- Locations
- 🇲🇽
Samuel altamirano Vallejo, Guadalajara, Jalisco, Mexico
🇲🇽Juan Carlos Serna Ojeda (INBIOMEDyC), Aguascalientes, Mexico
🇲🇽Instituto Nacional de Pediatria, Mexico City, Mexico
The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 76
- Registration Number
- NCT00719134
- Locations
- 🇺🇸
Pain Clinic at Beth Israel Deaconess Medical Center, Brookline, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath